Ola Didrik Saugstad1, Dagfinn Aune. 1. Department of Pediatric Research, Rikshospitalet, Oslo University Hospital, University of Oslo, Oslo, Norway. odsaugstad@rr-research.no
Abstract
BACKGROUND: The optimal arterial oxygen saturation in the first weeks of life is unknown for immature newborn infants. OBJECTIVES: To determine the effect of targeting high versus low oxygen saturation in the first weeks of life on the outcome of very low and extremely low birth weight infants. METHODS: Randomized and observational studies were sought that compared the outcomes in babies with high or low oxygen saturation targeting assessed by pulse oximetry. RESULTS: Ten studies were identified, of which 8 had severe retinopathy of prematurity (n = 3811) and 8 had bronchopulmonary dysplasia/lung problems (n = 4612) as outcomes. Two studies also provided survival data. The relative risk (RR) in favor of low SpO2 was 0.42 (95% CI 0.34-0.51) for severe retinopathy of prematurity, 0.73 (95% CI 0.63-0.86) for bronchopulmonary dysplasia/lung problems, and 1.12 (95% CI 0.86-1.45) for mortality. There was 1 randomized trial with retinopathy of prematurity, 3 with bronchopulmonary dysplasia/lung problems, and 1 with mortality as the outcome. When analyzing the randomized trial separately, the RR (95% CI) for severe retinopathy of prematurity was 0.48 (0.34-0.68), for bronchopulmonary dyslasia/lung problems it was 0.79 (0.64-0.97), and for mortality it was 1.27 (1.01-1.60). CONCLUSIONS: A low oxygen saturation approach reduces severe retinopathy of prematurity by 50%, i.e., from 20.9 to 9.5%, and bronchopulmonary dysplasia/lung problems by 25%, i.e., from 40.8 to 29.7%. Further randomized trials are needed to provide definite conclusions and to assess whether reducing oxygen saturation has an impact on mortality among very and extremely low birth weight infants.
BACKGROUND: The optimal arterial oxygen saturation in the first weeks of life is unknown for immature newborn infants. OBJECTIVES: To determine the effect of targeting high versus low oxygen saturation in the first weeks of life on the outcome of very low and extremely low birth weight infants. METHODS: Randomized and observational studies were sought that compared the outcomes in babies with high or low oxygen saturation targeting assessed by pulse oximetry. RESULTS: Ten studies were identified, of which 8 had severe retinopathy of prematurity (n = 3811) and 8 had bronchopulmonary dysplasia/lung problems (n = 4612) as outcomes. Two studies also provided survival data. The relative risk (RR) in favor of low SpO2 was 0.42 (95% CI 0.34-0.51) for severe retinopathy of prematurity, 0.73 (95% CI 0.63-0.86) for bronchopulmonary dysplasia/lung problems, and 1.12 (95% CI 0.86-1.45) for mortality. There was 1 randomized trial with retinopathy of prematurity, 3 with bronchopulmonary dysplasia/lung problems, and 1 with mortality as the outcome. When analyzing the randomized trial separately, the RR (95% CI) for severe retinopathy of prematurity was 0.48 (0.34-0.68), for bronchopulmonary dyslasia/lung problems it was 0.79 (0.64-0.97), and for mortality it was 1.27 (1.01-1.60). CONCLUSIONS: A low oxygen saturation approach reduces severe retinopathy of prematurity by 50%, i.e., from 20.9 to 9.5%, and bronchopulmonary dysplasia/lung problems by 25%, i.e., from 40.8 to 29.7%. Further randomized trials are needed to provide definite conclusions and to assess whether reducing oxygen saturation has an impact on mortality among very and extremely low birth weight infants.
Authors: Yvonne E Vaucher; Myriam Peralta-Carcelen; Neil N Finer; Waldemar A Carlo; Marie G Gantz; Michele C Walsh; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Abhik Das; Kurt Schibler; Wade Rich; Nancy S Newman; Betty R Vohr; Kimberly Yolton; Roy J Heyne; Deanne E Wilson-Costello; Patricia W Evans; Ricki F Goldstein; Michael J Acarregui; Ira Adams-Chapman; Athina Pappas; Susan R Hintz; Brenda Poindexter; Anna M Dusick; Elisabeth C McGowan; Richard A Ehrenkranz; Anna Bodnar; Charles R Bauer; Janell Fuller; T Michael O'Shea; Gary J Myers; Rosemary D Higgins Journal: N Engl J Med Date: 2012-12-27 Impact factor: 91.245
Authors: C L A Fernández; C A Fajardo; M V Favareto; A Hoyos; F X Jijón-Letort; M S Carrera; M E Yllescas; M S Romero Journal: J Perinatol Date: 2014-04-03 Impact factor: 2.521
Authors: Sharon A McGrath-Morrow; Thomas Lauer; Joseph M Collaco; Armando Lopez; Deepti Malhotra; Yuriy O Alekseyev; Enid Neptune; Robert Wise; Shyam Biswal Journal: Cytokine Date: 2013-10-17 Impact factor: 3.861
Authors: Colleen M Bartman; Aleksey Matveyenko; Christina Pabelick; Y S Prakash Journal: Am J Physiol Lung Cell Mol Physiol Date: 2021-01-06 Impact factor: 5.464
Authors: Elena Bergon-Sendin; Carmen Perez-Grande; David Lora-Pablos; Javier De la Cruz Bertolo; María Teresa Moral-Pumarega; Gerardo Bustos-Lozano; Carmen Rosa Pallas-Alonso Journal: Biomed Res Int Date: 2015-10-19 Impact factor: 3.411
Authors: Jacek J Pietrzyk; Przemko Kwinta; Embjorg J Wollen; Mirosław Bik-Multanowski; Anna Madetko-Talowska; Clara-Cecilie Günther; Mateusz Jagła; Tomasz Tomasik; Ola D Saugstad Journal: PLoS One Date: 2013-10-23 Impact factor: 3.240